Adverse metabolic effects have been associated with drugs used in the
therapy of hypertension, especially diuretics and beta-blockers. These
effects include electrolyte, glucose/insulin, lipid and uric acid dis
turbances, This may explain, at least in part, why early trials examin
ing the impact of antihypertensive pharmacotherapy with diuretics and
beta-blockers showed beneficial effects on coronary artery disease tha
t fell disappointingly short of the predicted effect, Among therapeuti
c drugs, diuretics cause disturbances in electrolyte homeostasis, e.g.
hypokalaemia, hypomagnesaemia, and hyponatraemia, In contrast, ACE in
hibitors cause hyperkalaemia under certain circumstances, Both diureti
cs and beta-blockers, especially nonselective beta-blockers that lack
intrinsic sympathomimetic capabilities, have been associated with dist
urbances in glucose/insulin metabolism and can cause deleterious alter
ations in the profile of circulating plasma lipids, Hyperuricaemia, as
sociated with diuretic use, appears to be a problem only in those pati
ents who are predisposed to high circulating levels of uric acid.